• Indian J Pharmacol
• v.45(2); Mar-Apr 2013
• PMC3660940

Indian J Pharmacol. 2013 Mar-Apr; 45(2): 199–200.

doi:  10.4103/0253-7613.108325

PMCID: PMC3660940

Olmesartan: Induced maculopapular rash

Aruna Bhushan and S. T. Ved Bhushan

Author information ► Article notes ► Copyright and License information ►

Abstract

Olmesartan medoxomil is an angiotensin receptor blocker (ARB) which is shown to be effective and well tolerated in hypertensive patients. It is a frequently prescribed antihypertensive as it is considered safe. Here, we report the case of a patient who developed maculopapular rash during the course of the treatment with olmesartan medoxomil.

KEY WORDS: Angiotensin receptor blockers, maculopapular rash, olmesartan

Formats:

• Article
 | 
• PubReader
 | 
• ePub (beta)
 | 
• Printer Friendly

Go to:

Abstract

Olmesartan medoxomil is an angiotensin receptor blocker (ARB) which is shown to be effective and well tolerated in hypertensive patients. It is a frequently prescribed antihypertensive as it is considered safe. Here, we report the case of a patient who developed maculopapular rash during the course of the treatment with olmesartan medoxomil.

KEY WORDS: